Functional Problems Shift Over Time Among Children After Brain Tumor Treatment
After completing treatment for brain tumor, children continue to experience problems with body function. These findings were published in...
Sep 11, 2025
Molecular testing unveils new insights into adolescent and young adult brain cancer
Part of a broader research study, the findings are helping to shape potential treatment approaches for patients with glioma based on the...
Aug 27, 2025
Nurses’ Role in Grief Support for Pediatric Brain Cancer Survival
In order for oncology nurses to provide comprehensive support to patients and families going through pediatric brain cancer diagnosis,...
Aug 26, 2025
Study Unveils Potential Therapeutic Pathways for Aggressive Pediatric Brain Tumor
A groundbreaking study led by researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and the Broad Institute of...
Aug 8, 2025
Childhood brain tumors develop early in highly specialized nerve cells, research reveals
A team of researchers at the Hopp Children's Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ) and Heidelberg...
Jul 8, 2025
Pediatric Brain Tumor Risk Increases With CT Radiation Exposure
Head and neck computed tomography (CT) imaging increases the risk for pediatric brain tumors, according to the findings of a study...
Jul 7, 2025
AI Predicts Pediatric Brain Tumor Relapse With Surprising Accuracy
Researchers have developed an AI system that predicts brain tumor recurrence in children using sequential MRI scans. [...] The approach...
Jul 4, 2025
FDA Grants Breakthrough Therapy Designation for BrainChild Bio’s B7-H3 CAR T-Cell Therapy for Incurable Pediatric Brain Tumors
BrainChild Bio, Inc., a clinical-stage biotechnology company developing CAR T-cell therapies to treat tumors in the central nervous...
Jun 28, 2025
Auditory Attention Decay Noted Post-Treatment in Pediatric Cerebellar Tumors
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
Apr 17, 2025
FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Apr 10, 2025

